Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Jordan

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 30, 2018
Evaluation of factors contributing to the response to fosaprepitant in a heterogeneous, moderately emetogenic chemotherapy population: an exploratory analysis of a randomized phase III trialCindy Weinstein, Karin Jordan, Stuart A Green, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 25, 2009
Reduction of chemotherapy-induced anorexia, nausea, and emesis through a structured nursing intervention: a cluster-randomized multicenter trialPatrick Jahn, Petra Renz, Joerg Stukenkemper, et al.
Frontiers in Oncology|May 14, 2023
Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myelomaNina Rosa Neuendorff, Boryana Boshikova, Lutz Frankenstein, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Quality of Online Information on Multiple Myeloma Available for LaypersonsHenrike Staemmler, Sandra Sauer, Emma Pauline Kreutzer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2020
Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple MyelomaFelix Krummradt, Sandra Sauer, Petra Pavel, et al.
Plos One|July 29, 2022
Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral sheddingJulia Tabatabai, Paul Schnitzler, Christiane Prifert, et al.
Frontiers in Neurology|March 4, 2022
The Emesis Trial: Depressive Glioma Patients Are More Affected by Chemotherapy-Induced Nausea and VomitingVera Dufner, Almuth Friederike Kessler, Larissa Just, et al.
Cancers|September 28, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple MyelomaMarc-Andrea Baertsch, Mathilde Fougereau, Thomas Hielscher, et al.
Journal of Geriatric Oncology|November 28, 2016
Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patientsMatti Aapro, Karin Jordan, Richard J Gralla, et al.
Cancers|July 24, 2021
Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationEva-Maria Klein, Sandra Sauer, Sabrina Klein, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 30, 2018
Evaluation of factors contributing to the response to fosaprepitant in a heterogeneous, moderately emetogenic chemotherapy population: an exploratory analysis of a randomized phase III trialCindy Weinstein, Karin Jordan, Stuart A Green, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 25, 2009
Reduction of chemotherapy-induced anorexia, nausea, and emesis through a structured nursing intervention: a cluster-randomized multicenter trialPatrick Jahn, Petra Renz, Joerg Stukenkemper, et al.
Frontiers in Oncology|May 14, 2023
Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myelomaNina Rosa Neuendorff, Boryana Boshikova, Lutz Frankenstein, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Quality of Online Information on Multiple Myeloma Available for LaypersonsHenrike Staemmler, Sandra Sauer, Emma Pauline Kreutzer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2020
Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple MyelomaFelix Krummradt, Sandra Sauer, Petra Pavel, et al.
Plos One|July 29, 2022
Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral sheddingJulia Tabatabai, Paul Schnitzler, Christiane Prifert, et al.
Frontiers in Neurology|March 4, 2022
The Emesis Trial: Depressive Glioma Patients Are More Affected by Chemotherapy-Induced Nausea and VomitingVera Dufner, Almuth Friederike Kessler, Larissa Just, et al.
Cancers|September 28, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple MyelomaMarc-Andrea Baertsch, Mathilde Fougereau, Thomas Hielscher, et al.
Journal of Geriatric Oncology|November 28, 2016
Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patientsMatti Aapro, Karin Jordan, Richard J Gralla, et al.
Cancers|July 24, 2021
Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationEva-Maria Klein, Sandra Sauer, Sabrina Klein, et al.
Pageof 11